Committees

Agenda for the 179th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 12 SEPTEMBER 2019, at 9 am

1.	MATTERS OF ADMINISTRATION
1.1	Welcome and apologies
1.2	Minutes and recommendations of the 178th MARC meeting
1.3	Declarations of potential conflicts of interest
2.	MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE
2.1	CARM quarterly report
3.	PHARMACOVIGILANCE REPORTS
3.1	Matters referred to the MARC under section 36 of the Medicines Act 1981
	3.1.1 Review of the risks of harm and chance of benefit of Cafergot (ergotamine tartrate + caffeine)
3.2	Matters referred to the MARC by Medsafe
	3.2.1 The use of topiramate during pregnancy for migraine prevention
	3.2.2 Serotonin reuptake inhibitors and persistent sexual dysfunction
	3.2.3 Dextromethorphan – benefit-risk review
	3.2.4 Shingrix (recombinant varicella zoster virus vaccine) Risk Management Plan
4.	MEDSAFE PHARMACOVIGILANCE ACTIVITIES
4.1	Report on standing agenda items
4.2	Medsafe pharmacovigilance activities
4.3	Prescriber Update
4.4	Quarterly summary of recent safety communications
5.	OTHER BUSINESS